Equities

IPCA Laboratories Ltd

IPCALAB:NSI

IPCA Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,454.35
  • Today's Change4.60 / 0.32%
  • Shares traded597.20k
  • 1 Year change+56.89%
  • Beta0.4030
Data delayed at least 15 minutes, as of Sep 19 2024 11:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue77,05062,44358,298
OPERATING EXPENSES
Cost of revenue total31,02427,31323,811
Selling, general and admin. expenses, total31,60424,74120,923
Depreciation/amortization3,5722,6162,324
Unusual expense(income)1,76300
Other operating expenses, total813317238
Total operating expense69,49555,44847,714
Operating income7,5566,99610,584
Other, net(52)124146
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes8,4277,45311,146
Provision for income taxes3,1352,5342,248
Net income after taxes5,2924,9198,898
Minority interest244(77)(57)
Net income before extra. Items5,4744,7138,841
Total extraordinary items------
Net income5,4744,7138,841
Inc.avail. to common excl. extra. Items5,4744,7138,841
Inc.avail. to common incl. extra. Items5,4744,7138,841
EPS RECONCILIATION
Basic/primary weighted average shares254254254
Basic/primary eps excl. extra items221935
Basic/primary eps incl. extra items221935
Dilution adjustment------
Diluted weighted average shares254254254
Diluted eps excl. extra items221935
Diluted eps incl. extra items221935
COMMON STOCK DIVIDENDS
DPS - common stock primary issue4.004.004.00
Gross dividend - common stock--1,0151,015
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1,26642767
SUPPLEMENTAL INCOME
Depreciation, supplemental3,3312,3622,122
Total special items1,728(132)114
NORMALISED INCOME
Normalized income before taxes10,1557,32111,260
Effect of special items on income taxes643(45)23
Income tax excluding impact of special items3,7782,4892,271
Normalized income after tax6,3784,8328,989
Normalized income avail. to common6,5594,6268,932
Basic normalized EPS261835
Diluted normalized EPS261835
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.